Autor:	Massarelli G, Antonio Muscari, P. Boni, Luciana Bastagli, V. Tomassetti, G. Poggiopollini, Paolo Emilio Puddu
Rok vydání:	2001
Předmět:	Pharmacology medicine.medical_specialty Randomization Triglyceride Cholesterol business.industry Vitamin E medicine.medical_treatment Atorvastatin General Medicine Placebo medicine.disease chemistry.chemical_compound Endocrinology chemistry Oral administration Internal medicine medicine Pharmacology (medical) Myocardial infarction Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	Cardiovascular Drugs and Therapy. 15:453-458
ISSN:	0920-3206
Popis:	C3 complement is produced in response to macrophage activation and is a reliable marker of the risk of myocardial infarction in men. This study was designed to ascertain whether the treatment with atorvastatin, a powerful cholesterol lowering drug, and/or vitamin E, a natural antioxidant, may induce a short term decrease in serum C3 in subjects with persistently elevated levels. From an initial random sample of 1100 men aged 55–64 years, 140 subjects with 3 consecutive C3 measurements in the high tertile (>1.19 g/l) were selected. Those with total cholesterol
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4b810c281594d19c1120988041cbb3e1 https://doi.org/10.1023/a:1013314227857 Zobrazit plný text záznamu Full text from SpringerLink